albuterol has been researched along with Kidney Failure, Chronic in 19 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In order to evaluate the efficiency of albuterol sulfate (salbutamol) in lowering of potassium levels in uremic children with hyperkalemia, we intravenously administered salbutamol 30 micrograms/min (total doses 0." | 3.67 | [Correction of hyperkalemia with intravenous salbutamol in children with chronic renal insufficiency]. ( Arias-Reyes, JA; Dubey-Ortega, LA; Matos-Martínez, M; Velásquez-Jones, L, 1989) |
| "Seventeen chronic renal failure patients referred to the Nephrology Unit between October 1, 1997 and March 31, 1998 for hemodialysis were randomized." | 2.69 | Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe? ( Gilad, E; Houri, S; Krupnik, Z; Mandelberg, A; Matas, Z; Priel, IE; Smetana, S, 1999) |
| "Acute treatment of hyperkalemia in patients with end-stage renal disease requires temporizing measures to shift potassium rapidly from the extracellular to the intracellular fluid compartments until hemodialysis can be initiated." | 2.68 | Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. ( Allon, M; Shanklin, N, 1996) |
| "Ten patients with acute and 60 with chronic renal failure (both groups having hyperkalaemia), were managed at Kenyatta National Hospital in the medical wards and Renal Unit between August, 1995 and January, 1996." | 2.68 | Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. ( Kayima, JK; McLigeyo, SO; Ngugi, NN, 1997) |
| "Hyperkalemia is one of the frequent medical emergencies in patients with chronic renal failure (CRF)." | 2.67 | Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. ( Chiang, SS; Huang, TP; Liou, HH; Wu, SC; Yang, WC, 1994) |
| "Three groups of patients with acute or chronic renal failure (GFR less than 5 ml/min) and hyperkalaemia (K+ greater than or equal to 6 mEq/l), similar in age, serum creatinine and pretreatment K+." | 2.66 | Treatment of hyperkalaemia in renal failure: salbutamol v. insulin. ( Campistol, JM; Cases, A; Lens, XM; Montoliu, J; Revert, L, 1989) |
| "Hyperkalemia is a life threatening emergency and warrants immediate treatment because of its deleterious cardiac consequences." | 2.39 | Hyperkalemia: therapeutic options in acute and chronic renal failure. ( Harps, E; Kemper, MJ; Müller-Wiefel, DE, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 11 (57.89) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tochihara, Y | 1 |
| Whiting, MJ | 1 |
| Barbara, JA | 1 |
| Mangoni, AA | 1 |
| Sieber, U | 1 |
| Escher, R | 1 |
| Wallmann, D | 1 |
| Covic, A | 1 |
| Goldsmith, DJ | 1 |
| Gusbeth-Tatomir, P | 1 |
| Covic, M | 1 |
| Allon, M | 2 |
| Shanklin, N | 2 |
| Liou, HH | 2 |
| Chiang, SS | 2 |
| Wu, SC | 2 |
| Yang, WC | 2 |
| Huang, TP | 2 |
| McClure, RJ | 1 |
| Prasad, VK | 1 |
| Brocklebank, JT | 1 |
| Campese, VM | 1 |
| Smogorzewski, M | 1 |
| Rambausek, M | 1 |
| Kluge, R | 1 |
| Kemper, MJ | 1 |
| Harps, E | 1 |
| Müller-Wiefel, DE | 1 |
| Kim, HJ | 1 |
| Ngugi, NN | 1 |
| McLigeyo, SO | 1 |
| Kayima, JK | 1 |
| Mandelberg, A | 1 |
| Krupnik, Z | 1 |
| Houri, S | 1 |
| Smetana, S | 1 |
| Gilad, E | 1 |
| Matas, Z | 1 |
| Priel, IE | 1 |
| Helfrich, E | 1 |
| de Vries, TW | 1 |
| van Roon, EN | 1 |
| Montoliu, J | 3 |
| Almirall, J | 1 |
| Ponz, E | 1 |
| Campistol, JM | 2 |
| Revert, L | 3 |
| Lens, XM | 2 |
| Cases, A | 1 |
| de Cornelissen, F | 1 |
| Bermudes, H | 1 |
| Saint-Loubert, M | 1 |
| Marty, L | 1 |
| Emond, C | 1 |
| Fontanier, P | 1 |
| Arias-Reyes, JA | 1 |
| Matos-Martínez, M | 1 |
| Velásquez-Jones, L | 1 |
| Dubey-Ortega, LA | 1 |
2 reviews available for albuterol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Hyperkalemia: therapeutic options in acute and chronic renal failure.
Topics: Acute Disease; Acute Kidney Injury; Adolescent; Adrenergic beta-Agonists; Albuterol; Child; Child, P | 1996 |
Salbutamol for hyperkalaemia in children.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Child; Child, Preschool | 2001 |
7 trials available for albuterol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effects of pre- vs. intra-dialysis folic acid on arterial wave reflections and endothelial function in patients with end-stage renal disease.
Topics: Aged; Albuterol; Arginine; Cross-Over Studies; Drug Administration Schedule; Endothelium, Vascular; | 2008 |
Haemodialysis acutely improves endothelium-independent vasomotor function without significantly influencing the endothelium-mediated abnormal response to a beta 2-agonist.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Aorta; Blood Flow Velocity; Endothelium, Vascular; Femal | 2004 |
Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure.
Topics: Administration, Inhalation; Aged; Albuterol; Female; Humans; Hyperkalemia; Infusions, Intravenous; K | 1994 |
Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Cross-Over Studies; Drug Synergism; Female; Humans | 1996 |
Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
Topics: Acute Kidney Injury; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol | 1997 |
Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe?
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Double-Blind Method; Female; | 1999 |
Treatment of hyperkalaemia in renal failure: salbutamol v. insulin.
Topics: Acute Kidney Injury; Aged; Albuterol; Drug Therapy, Combination; Electrocardiography; Female; Humans | 1989 |
10 other studies available for albuterol and Kidney Failure, Chronic
| Article | Year |
|---|---|
[What is your diagnosis? Hyperkalemia in acute kidney failure in known chronic kidney failure].
Topics: Acute Kidney Injury; Aged; Albuterol; Bronchodilator Agents; Calcium Gluconate; Critical Care; Elect | 2009 |
Effect of albuterol treatment on subsequent dialytic potassium removal.
Topics: Adult; Aged; Albuterol; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middl | 1995 |
Treatment of hyperkalaemia using intravenous and nebulised salbutamol.
Topics: Administration, Intranasal; Adolescent; Albuterol; Child; Child, Preschool; Humans; Hyperkalemia; In | 1994 |
Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study.
Topics: Administration, Inhalation; Aged; Albuterol; Analysis of Variance; Female; Humans; Hyperkalemia; Inf | 1994 |
[beta-Sympathomimetics against hyperkalemia in kidney failure].
Topics: Administration, Inhalation; Albuterol; Humans; Hyperkalemia; Kidney Failure, Chronic; Renal Dialysis | 1993 |
Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Drug Therapy, Combination; Female; Heart | 1997 |
Treatment of hyperkalaemia in renal failure with salbutamol inhalation.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Albuterol; Electrocardiography; Female; | 1990 |
[Use of salbutamol in the treatment of severe hyperkalemia in hemodialysed patients].
Topics: Albuterol; Humans; Hyperkalemia; Infusions, Intravenous; Kidney Failure, Chronic; Renal Dialysis | 1989 |
[Correction of hyperkalemia with intravenous salbutamol in children with chronic renal insufficiency].
Topics: Adolescent; Albuterol; Child; Drug Evaluation; Electrocardiography; Female; Humans; Hyperkalemia; In | 1989 |
Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
Topics: Adult; Aged; Albuterol; Diabetes Mellitus, Type 1; Female; Humans; Hyperkalemia; Kidney Failure, Chr | 1987 |